Genmab A/S
F:GE9
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Genmab A/S
F:GE9
|
DK |
|
W
|
Wienerberger AG
VSE:WIE
|
AT |
|
A
|
Abbott Laboratories
BMV:ABT
|
US |
|
F
|
Fresnillo PLC
BMV:FRES
|
MX |
|
A
|
Altria Group Inc
SWB:PHM7
|
US |
|
M
|
Marvell Technology Group Ltd
F:9MW
|
US |
|
SGS SA
F:SUVA
|
CH |
|
E
|
Exor NV
XMUN:EYX
|
NL |
|
A
|
Alibaba Health Information Technology Ltd
F:TWY
|
HK |
|
Largo SA
PAR:ALLGO
|
FR |
|
S
|
Swiss Re AG
F:SR9
|
CH |
|
L
|
L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes Georges Claude SA
XHAM:AIL
|
FR |
|
W
|
Wolters Kluwer NV
XMUN:WOSB
|
NL |
|
10X Genomics Inc
F:1KJ
|
US |
|
Z
|
Zhaojin Mining Industry Co Ltd
XMUN:ZVL
|
CN |
|
A
|
AXA SA
XMUN:AXA
|
FR |
|
T
|
Teradyne Inc
XMUN:TEY
|
US |
|
R
|
Ratchthani Leasing PCL
SET:THANI
|
TH |
|
D
|
Dollar Tree Inc
XMUN:DT3
|
US |
|
Dropbox Inc
NASDAQ:DBX
|
US |
|
X
|
Xenia Hotels & Resorts Inc
F:0XHR
|
US |
|
Intelligo Technology Inc
TWSE:7749
|
KY |
|
Aena SME SA
F:A441
|
ES |
|
F
|
First Tractor Co Ltd
F:FTP
|
CN |
Bankruptcy Probability
Genmab A/S's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Genmab A/S Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DK |
|
Genmab A/S
CSE:GMAB
|
139.3B DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
468.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
219.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
185.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
132.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
77.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
52.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
84.7B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
58.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
42.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Genmab A/S's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Genmab A/S has total debt of 5B USD. This includes both short-term (0 USD) and long-term (5B USD) debt.
You can find a full breakdown on its Balance Sheet.